Table: Shin Nippon Biomedical - 6-MTH group results

Shin Nippon Biomedical Laboratories

07/11/2023 06:00

Nov 7 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             11.88               10.35            30.37    
                 (+14.8 pct)         (+30.0 pct)      (+21.0 pct) 
  Operating          2.35                2.31             5.02    
                 (+1.5 pct)          (+17.5 pct)      (-4.3 pct)  
  Recurring          3.76                5.93             7.18    
                 (-36.6 pct)        (+134.4 pct)      (-21.9 pct) 
  Net                2.97                4.42             4.78    
                 (-32.9 pct)         (+26.1 pct)      (-21.1 pct) 
  EPS             71.24 yen          106.16 yen       114.81 yen  
  Ann Div                             50.00 yen        50.00 yen  
  -Q2 div         20.00 yen           20.00 yen                   
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T